PURPOSE OF REVIEW: This article reviews recently published evidence regarding the role of vitamin D in the physiopathology of physical frailty in elderly populations and its role in the management of this geriatric condition. RECENT FINDINGS: Some recent studies have found a low level of 25-hydroxyvitamin D, considered the best marker of vitamin D status, in frail individuals. All prospective studies consistently report that low vitamin D status is associated with an increased risk of becoming frail. Recent studies also suggest that the relationship between vitamin D status and frailty is largely mediated by the development of sarcopenia. Very few well designed randomized controlled trials are available that assess the effectiveness of vitamin D supplementation in the prevention or management of frailty. In the absence of specific guidelines, a minimal serum 25-hydroxyvitamin D level of 75 nmol/l is proposed for frail elderly patients by some scientific societies. The doses necessary to reach this target are between 800 and 2000 IU/day. SUMMARY: Several studies suggest a potential effect of vitamin D on physical frailty but large clinical trials are lacking at this time to provide solid evidence of clinical benefit.
PURPOSE OF REVIEW: This article reviews recently published evidence regarding the role of vitamin D in the physiopathology of physical frailty in elderly populations and its role in the management of this geriatric condition. RECENT FINDINGS: Some recent studies have found a low level of 25-hydroxyvitamin D, considered the best marker of vitamin D status, in frail individuals. All prospective studies consistently report that low vitamin D status is associated with an increased risk of becoming frail. Recent studies also suggest that the relationship between vitamin D status and frailty is largely mediated by the development of sarcopenia. Very few well designed randomized controlled trials are available that assess the effectiveness of vitamin D supplementation in the prevention or management of frailty. In the absence of specific guidelines, a minimal serum 25-hydroxyvitamin D level of 75 nmol/l is proposed for frail elderly patients by some scientific societies. The doses necessary to reach this target are between 800 and 2000 IU/day. SUMMARY: Several studies suggest a potential effect of vitamin D on physical frailty but large clinical trials are lacking at this time to provide solid evidence of clinical benefit.
Authors: Karen S van den Berg; Johanna M Hegeman; Rob H S van den Brink; Didi Rhebergen; Richard C Oude Voshaar; Radboud M Marijnissen Journal: Int J Geriatr Psychiatry Date: 2021-02-25 Impact factor: 3.485
Authors: María Esther Rubio-Ruiz; Verónica Guarner-Lans; Israel Pérez-Torres; María Elena Soto Journal: Int J Mol Sci Date: 2019-02-02 Impact factor: 5.923
Authors: Ana Moradell; David Navarrete-Villanueva; Ángel I Fernández-García; Jorge Marín-Puyalto; Alejandro Gómez-Bruton; Raquel Pedrero-Chamizo; Jorge Pérez-Gómez; Ignacio Ara; Jose A Casajus; Alba Gómez-Cabello; Germán Vicente-Rodríguez Journal: Nutrients Date: 2020-10-01 Impact factor: 5.717